Introduction {#s1}
============

Hearing loss is one of the most common sensory disorders in humans, and around 466 million people worldwide have disabling hearing loss. Sensorineural hearing loss might result from genetic causes, the use of ototoxic drugs, excessive noise exposure, and aging. Sensory hair cells in the cochlea detect sound and are responsible for converting mechanical signals into electrical signals, and aminoglycosides and excessive noise exposure can induce caspase-mediated apoptosis in hair cells and thus lead to hearing loss ([@B1], [@B2]).

Increasing evidence suggests that inflammatory processes play significant roles in the response to cochlear injury. For example, the expression levels of pro-inflammatory cytokines, chemokines, and cell adhesion molecules are increased in both acute and chronic noise-exposed mouse cochleae ([@B3]), and several clinical studies have shown that inflammation is a significant component of the mechanisms underlying presbycusis ([@B4]). Tumor necrosis factor (Tnf, also known as Tnf-α) is a central circulating factor that is essential for the systemic inflammatory mechanism. Tnf expression is increased in the mouse cochlea following acute and chronic noise exposure ([@B3], [@B5]), and exposure to Tnf can induce hair cell damage and apoptosis in cultured cochlear explants ([@B6]).

Nuclear factor of activated T cells 4 (*Nfatc4*), also known as *Nfat3*, encodes a member of the nuclear factor of activated T cells (NFAT) protein family, which are integral proteins in the development and function of the immune system. The activation of the NFAT family is controlled by calcineurin, a Ca^2+^-dependent phosphatase. Originally identified in T cells as inducers of cytokine gene expression ([@B7]), NFAT proteins have been shown to play various roles in cells outside of the immune system, including functions in cell development, differentiation, and adaptation ([@B8]) and in neuronal excitability ([@B9]). Nfatc4 is also involved in cell apoptosis in many tissues and organs. Nfatc4 is anti-apoptotic and mediates cell survival in some tissues, such as neurons ([@B10]), and the NMDAR-Nfatc4-BDNF pathway contributes to cell survival during cortical development ([@B11]). However, in other tissues, such as glioma cells and renal tubular cells, Nfatc4 mediates cell apoptosis. In glioma cells, Nfatc4 activation is a prerequisite for the induction of DOX-mediated apoptosis ([@B12]). In renal tubular cells, a carboplatin-mediated increase in reactive oxygen species (ROS) leads to Nfatc4 activation and cell apoptosis, and treatment with N-acetylcysteine, an antioxidant, blocks Nfatc4 activation and thus prevents cell apoptosis ([@B13]).

However, the expression and function of Nfatc4 in the cochlea remains unclear. In this study, we found that Nfatc4 is expressed in the cochlear hair cells and that when the hair cells were challenged by neomycin (an ototoxic drug) Nfatc4 translocated to the nucleus, enhanced the expression of *Tnf* and its downstream targets, and led to hair cell apoptosis. Furthermore, Nfatc4-deficient hair cells showed reduced sensitivity to ototoxic drugs and noise exposure compared to wild type (WT) controls. The Tnf-mediated apoptosis pathway was attenuated in Nfatc4-deficient hair cells, and this might be the reason for the reduced sensitivity of Nfatc4-deficient hair cells to injury.

Materials and Methods {#s2}
=====================

Mice and Genotyping
-------------------

Nfatc4 knockout mice were generated by Professor Gerald R. Crabtree ([@B14]) and provided by Dr. Yan-Ai Mei of Fudan University. As previously described ([@B9], [@B14]), *Nfatc4* knockout (*Nfatc4*^−/−^) mice were backcrossed 10--12 times onto C57BL/6 mice to obtain homozygous *Nfatc4* mice. *Nfatc4*^−/−^ and WT mice (littermates) were genotyped by PCR. The three primers used in genotyping were CCG GTG CAT CCC GGG TAA CCA ATC AGA GA; TCC TCA TCC TCG CAG CTT GCG GCC CC; and AGC GTT GGC TAC CCG TGA TAT TGC TGA AGA. The genotypes were identified by a 300 bp WT band and a 700 bp mutant band. Mice of both sexes were used. This study was carried out in strict accordance with the "Guiding Directive for Humane treatment of Laboratory Animals" issued by the Chinese National Ministry of Science and Technology in 2006. All experiments were approved by the Shanghai Medical Experimental Animal Administrative Committee (Permit Number: 2009-0082), and all efforts were made to minimize suffering and reduce the number of animals used.

Experimental Protocol (*In vivo* Studies)
-----------------------------------------

Hearing thresholds were measured in anesthetized postnatal day (P)30 or P33 mice by auditory brainstem response (ABR) analysis as described previously ([@B2]). The hearing thresholds were assessed at four frequencies (8, 16, 24, and 32 kHz) using a TDT system (Tucker Davies Technologies).

To explore the effect of Nfatc4 deficiency on sensitivity to noise exposure in cochlear hair cells, the hearing function of P30 *Nfatc4*^−/−^ and WT mice (littermates) was examined by ABR. Twenty-four hours after the ABR test, the mice were exposed to noise at 118 dB (8--16 kHz) for 2 h. At 2 days after noise exposure, hearing function was examined again by ABR, after which the mice were sacrificed and their cochleae were removed and fixed in 4% paraformaldehyde (PFA). After decalcification, the cochlear epithelium was prepared for morphological analysis.

Experimental Protocol (*In vitro* Studies)
------------------------------------------

Cochlear sensory epithelium was dissected from P2 mice and cultured as previously reported ([@B15]). Neomycin (1 mM, Sigma) was added to the medium for 6 h to kill hair cells. After neomycin was removed, the tissues were cultured in serum-free medium for an additional 24 h before fixation. For the Tnf inhibition experiment, lenalidomide (Len) or etanercept (ETA) and neomycin were added simultaneously. For the inhibition of calcineurin/NFAT signaling, cyclosporin A (CsA) or tacrolimus (FK506) and neomycin were added simultaneously.

Immunofluorescence and TUNEL Staining
-------------------------------------

Rabbit polyclonal anti-myosin VIIA (Myo7a) (Proteus Biosciences, 1:1,000 dilution), goat polyclonal anti-SRY (sex-determining region Y)-box 2 (Sox2) (Santa Cruz Biotechnology, 1:1,000 dilution), and mouse monoclonal anti-Nfatc4 (Santa Cruz Biotechnology, 1:200 dilution) were used. Corresponding donkey anti-rabbit, anti-goat, or anti-mouse secondary antibodies conjugated with Alexa Fluor 488, Alexa Fluor 568, or Alexa Fluor 647 (ThermoFisher Scientific, 1:500 dilution) were used. Immunofluorescence staining was performed as previously reported ([@B2]). A TUNEL Kit (Roche) was used to detect apoptotic cells according to the manufacturer\'s instructions. Specimens were examined by confocal fluorescence microscopy (Leica SP8).

Real-Time PCR
-------------

Real-time PCR was performed on cochlear explants. A total of 2 μg total RNA was used for reverse transcription with Superscript III reverse transcriptase (Invitrogen), and real-time PCR was performed on an ABI 7500 real-time PCR system (Applied Biosystems) using the TB Green PrimeScript RT-PCR Kit (Takara). All primers were designed to flank individual exons and were tested by PCR. The optimized conditions were held constant for each sample to assure valid comparisons of the results. Primer sets were as follows: *Actb* (F) tct ttg cag ctc ctt cgt tg; (R) tcc ttc tga ccc att ccc ac; *Nfatc4* (F) tcg gag agg aaa agg agc c; (R) tgg tga gtg cat ccc tgg; *Tnf* (F) gcc tcc ctc tca tca gtt ct; (R) gca gcc ttg tcc ctt gaa g; *Casp8* (F) aac tgc gtt tcc tac cga ga; (R) cct tgt tcc tcc tgt cgt ct; *Casp3* (F) gag cag ctt tgt gtg tgt ga; (R) tgt ctc aat gcc aca gtc ca; *Casp9* (F) gga ccg tga caa act tga gc; *Casp9* (R) tct cca tca aag ccg tga cc. *Actb* was used as a housekeeping gene for control purposes. Each PCR reaction was carried out in triplicate, and the relative quantification of gene expression was analyzed using the 2^−ΔΔ*CT*^ method with *Actb* as the endogenous reference.

Cell Counting and Statistical Analysis
--------------------------------------

To quantify the immunostaining-positive cells, nine separate segments along the entire cochlea were selected from the apex to the base (corresponding to approximately 4.0, 5.6, and 8.0 kHz in the apical turn; 11.3, 16.0, and 22.6 kHz in the middle turn; and 32.0, 45.2, and 64.0 kHz in the basal turn). Data are presented as the mean ± SD. Student\'s 2-tailed *t*-test was used to analyze the differences between two groups in [Figures 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}. For the comparison of differences among three groups in [Figure 6E](#F6){ref-type="fig"}, one-way ANOVA followed by Bonferroni *post-test* for multiple comparisons was used. For the comparison of differences among three or more groups in other figures, two-way ANOVA followed by Bonferroni *post-test* for multiple comparisons was used. *P* \< 0.05 was considered significant, and the *p*-values are presented in the figures (^\*^indicates *p* \< 0.05, ^\*\*^indicates *p* \< 0.01, and ^\*\*\*^indicates *p* \< 0.001).

Results {#s3}
=======

Nfatc4 Was Expressed in the Cochlear Hair Cells
-----------------------------------------------

Immunofluorescence staining with the anti-Nfatc4 antibody was performed to determine the extent of Nfatc4 expression in the mouse cochlea. Myo7a and Sox2 were used as hair cell and supporting cell markers, respectively. Double staining of Nfatc4 and Myo7a showed that Nfatc4 was expressed in hair cells in all three turns of the cochlea in both the neonatal and adult mice ([Figure 1A](#F1){ref-type="fig"}). Double immunofluorescence staining of Nfatc4 and Sox2 showed that Nfatc4 was not expressed in cochlear supporting cells ([Figure 1A](#F1){ref-type="fig"}).

![Nfatc4 was expressed in the cochlear hair cells, and *Nfatc4*^−/−^ mice showed normal cochlear development and hearing function. **(A)** Nfatc4 immunofluorescence staining in the cochlear hair cells (middle turns) of P2 and P30 WT mice. Myo7a and Sox2 were used as hair cell and supporting cell markers, respectively. **(B)** Myo7a immunofluorescence in cochlear hair cells (middle turn) of adult *Nfatc4*^−/−^ and WT mice. **(C)** The hearing thresholds of ABR measurement in the adult *Nfatc4*^−/−^ and WT mice. **(D)** The numbers of hair cells in *Nfatc4*^−/−^ and WT mice. Scale bars: 25 μm. *n* = 5.](fimmu-10-01660-g0001){#F1}

*Nfatc4*^−/−^ Mice Showed Normal Cochlear Development and Hearing Function
--------------------------------------------------------------------------

To explore the role of Nfatc4 in the development of cochlear hair cells and in hearing function, we used *Nfatc4*^−/−^ mice. In the adult stage, the morphological features and quantities of cochlear hair cells in the *Nfatc4*^−/−^ mice were similar to the WT controls ([Figures 1B,D](#F1){ref-type="fig"}). The hearing function of adult *Nfatc4*^−/−^ mice was normal at 8, 16, 24, and 32 KHz as demonstrated by ABR measurement data ([Figure 1C](#F1){ref-type="fig"}). These results suggested that *Nfatc4* is not a critical gene for cochlear development.

Cochlear Hair Cells in *Nfatc4*^−/−^ Mice Showed Reduced Sensitivity to Aminoglycoside Antibiotic-Induced Ototoxicity
---------------------------------------------------------------------------------------------------------------------

We next investigated the role of Nfatc4 in hair cell injury using an aminoglycoside antibiotic injury model. In this model, the sensitivity of hair cells to ototoxic drug injury increased from the apical turn to the basal turn. Cultured cochlear epithelium tissues from *Nfatc4*^−/−^ and WT mice were treated with 1 mM neomycin for 6 h and harvested after an additional 24 h in culture ([Figure 2A](#F2){ref-type="fig"}). Myo7a staining was then used to identify the remaining hair cells. In the WT control group with neomycin administration, the numbers of inner hair cells (IHCs) were 12.25 ± 0.5, 6.25 ± 1.71, and 4.75 ± 0.95 cells/100 μm in the apical, middle, and basal turns, respectively ([Figures 2B,D](#F2){ref-type="fig"}), and the numbers of outer hair cells (OHCs) were 43.50 ± 3.11, 12.25 ± 1.71, and 1.00 ± 1.15 cells/100 μm in the apical, middle, and basal turns, respectively ([Figures 2B,C](#F2){ref-type="fig"}). In the *Nfatc4*^−/−^ cochlear epithelium with neomycin administration, more hair cells were observed, and there were 12.5 ± 0.58, 9.75 ± 1.71, and 7.00 ± 1.41 cochlear IHCs/100 μm and 44.50 ± 1.91, 40.25 ± 2.22, and 16.25 ± 1.71 cochlear OHCs/100 μm in the apical, middle, and basal turns, respectively ([Figures 2B--D](#F2){ref-type="fig"}). The numbers of hair cells in the middle and basal turns were significantly greater in the cochlear epithelium from *Nfatc4*^−/−^ mice compared with control mice, indicating that *Nfatc4*^−/−^ cochlear hair cells were less sensitive to aminoglycoside antibiotic-induced injury.

![Cochlear hair cells in *Nfatc4*^−/−^ mice showed reduced sensitivity to aminoglycoside antibiotic-induced ototoxicity. **(A)** The diagram of the assay. Cochlear sensory epithelium samples from P2 *Nfatc4*^−/−^ and WT mice were dissected out and allowed to recover for 12 h. The samples were treated with 1 mM neomycin for 6 h, allowed to recover for 24 h, and then used for immunostaining. **(B)** The representative Myo7a immunofluorescence staining of sensory epithelium from *Nfatc4*^−/−^ and WT mice after neomycin treatment. **(C,D)** Quantification of inner hair cells (IHCs) and outer hair cells (OHCs). The numbers of IHCs and OHCs in the middle and basal turns were significantly greater in the cochlear epithelium from *Nfatc4*^−/−^ mice than in WT mice after neomycin treatment. Scale bar = 25 μm. \*indicates *p* \< 0.05 and \*\*\*indicates *p* \< 0.001. *n* = 5.](fimmu-10-01660-g0002){#F2}

Nfatc4 Deficiency Protected Against Noise-Induced Hearing Loss and Hair Cell Loss
---------------------------------------------------------------------------------

To further explore the role of Nfatc4 in the adult cochlea, we used a noise exposure hair cell injury model. In this model, the sensitivity of hair cells to noise injury depends on the noise frequency, intensity, and duration. In this experiment, adult mice were exposed to 118 dB noise (8--16 kHz) for 2 h, which leads to OHC loss in the apical-middle, middle, and basal turns and thus results in permanent hearing loss ([@B16]). Hearing function was examined by ABR at 2 days after noise exposure, and then the cochleae were harvested ([Figure 3A](#F3){ref-type="fig"}). In the control group, noise exposure led to significant OHC loss in the cochlear turn at 11.3, 16.0, 22.6, 32.0, 45.2, and 64.0 kHz, which was consistent with results from a previous study ([@B16]). However, in *Nfatc4*^−/−^ mice the noise-induced loss of OHCs was significantly decreased in the middle and basal turns (at 16.0, 22.6, 32.0, 45.2, and 64.0 kHz) compared with control mice ([Figures 3B,C](#F3){ref-type="fig"}), indicating that adult *Nfatc4-*deficient cochlear hair cells were more tolerant of noise.

![Nfatc4-deficient mice displayed enhanced resistance to hearing loss induced by noise exposure. **(A)** The diagram of the assay for **B--D**. P30 *Nfatc4*^−/−^ and WT mice (littermates) were examined by ABR, then 24 h later exposed to 118 dB noise (8--16 kHz) for 2 h. At 2 days after noise exposure, hearing function was examined again by ABR and the mouse cochleae were harvested. **(B)** The representative Myo7a immunofluorescence staining of sensory epithelium from *Nfatc4*^−/−^ and WT mice after noise exposure. **(C)** Quantification of inner hair cells (IHCs) and outer hair cells (OHCs). The numbers of OHCs in the middle and basal turns were significantly greater in the cochlear epithelium from *Nfatc4*^−/−^ mice than in WT mice after noise exposure. **(D)** Pure-tone ABR thresholds and threshold shift of *Nfatc4*^−/−^ mice and WT mice after noise exposure. Scale bar = 30 μm. *n* = 5. \*\*\**P* \< 0.001 vs. the WT+Noise group.](fimmu-10-01660-g0003){#F3}

At 2 days after noise exposure, the WT mice had significant hearing loss, as demonstrated by the increased ABR thresholds at 8, 16, 24, and 32 kHz ([Figure 3D](#F3){ref-type="fig"}). In Nfatc4-deficient mice, the ABR threshold shifts were significantly lower at all frequencies compared with the control mice after noise exposure ([Figure 3D](#F3){ref-type="fig"}), suggesting that Nfatc4 deficiency protects against noise-induced hearing loss *in vivo*.

Neomycin Treatment Triggered Nfatc4 Nuclear Translocation, Tnf Pathway Activation, and Hair Cell Apoptosis
----------------------------------------------------------------------------------------------------------

Previous studies have reported Nfatc4 nuclear translocation in response to stress, such as methamphetamine-induced neuronal injury ([@B17]). In this study, we also observed Nfatc4 translocation from the cytoplasm to the nucleus when the hair cells were challenged by neomycin exposure. Under normal conditions, Nfatc4 was located in the cytoplasm of hair cells ([Figures 4A,B](#F4){ref-type="fig"}). After the neomycin treatment, Nfatc4 was translocated to the hair cell nuclei ([Figure 4C](#F4){ref-type="fig"}). Neomycin-induced Nfatc4 nuclear translocation occurred in nearly all the hair cells across the cochlear length as shown in [Figure 4D](#F4){ref-type="fig"}. In previous studies, chromatin immunoprecipitation assays confirmed that the recruitment of Nfatc4 to the *Tnf* promoter was required in ultraviolet radiation-induced cell death ([@B18]), indicating that Tnf is a target of Nfatc4. In this study, we explored the expression of *Tnf* and its downstream signaling in cell apoptosis. As [Figure 4E](#F4){ref-type="fig"} shows, after neomycin treatment the expression levels of *Tnf*, *Casp8*, and *Casp3* were significantly increased, suggesting that the Tnf pathway might play roles in neomycin-induced hair cell death. In addition, the mRNA expression of *Nfatc4* was increased after neomycin treatment ([Figure 4E](#F4){ref-type="fig"}).

![Neomycin treatment triggered Nfatc4 nuclear translocation, Tnf pathway activation, and hair cell apoptosis. **(A--C)** Immunofluorescence staining showed the translocation of Nfatc4 from the cytoplasm to the nucleus. **(D)** The cross-sectional view of Nfatc4 staining in neomycin-treated cochlear epithelium. **(E)** qPCR analysis showed that *Nfatc4, Tnf*, *Casp3, Casp9*, and *Casp8* mRNA expression increased in the cochlear epithelium after neomycin damage. Scale bar = 25 μm. \*indicates *p* \< 0.05, \*\*indicates *p* \< 0.01, and \*\*\*indicates *p* \< 0.001 vs. the Con group. *n* = 5.](fimmu-10-01660-g0004){#F4}

The Tnf-Mediated Cell Apoptosis Pathway Was Inhibited in Nfatc4-Deficient Cochleae After Exposure to Aminoglycoside Antibiotics
-------------------------------------------------------------------------------------------------------------------------------

TUNEL staining was used to detect hair cell apoptosis ([Figure 5A](#F5){ref-type="fig"}). In the WT control group, there were 13 ± 1.00 TUNEL+/Myo7a+ cells/100 μm in the middle turn of the cochlear epithelium after neomycin treatment. Consistent with the above results, the number of apoptotic hair cells was significantly decreased in the *Nfatc4*^−/−^ cochlear epithelium to 3.2 ± 1.30 TUNEL+/Myo7a+ cells/100 μm in the middle turn (*p* \< 0.001, [Figures 5B,C](#F5){ref-type="fig"}). In the Nfatc4-deficient cochlear epithelium, the expression levels of *Tnf* and its downstream cascade (*Casp8* and *Casp3*) were significantly lower compared with the WT group after neomycin treatment ([Figure 5D](#F5){ref-type="fig"}), indicating that the neomycin-induced and Tnf-mediated extrinsic apoptosis pathway was attenuated by Nfatc4 deficiency. However, the expression levels of *Casp9* were not significantly changed by Nfatc4 deficiency ([Figure 5D](#F5){ref-type="fig"}), suggesting that the neomycin-induced intrinsic apoptosis pathway was not inhibited by Nfatc4 deficiency. These results indicated that Nfatc4 deficiency attenuates the hair cell apoptosis induced by neomycin injury, and this might be due to inhibition of the Tnf pathway.

![The Tnf-mediated cell apoptosis pathway was inhibited and hair cell apoptosis was decreased in Nfatc4-deficient cochleae after neomycin exposure. **(A)** The diagram of the assay for **(B--D)**. Cochlear sensory epithelium samples from P2 *Nfatc4*^−/−^ and WT mice were dissected out and allowed to recover for 12 h. The samples were treated with 1 mM neomycin for 6 h, allowed to recover for 12 h, and then used for TUNEL staining. **(B)** The representative Myo7a and TUNEL staining of sensory epithelium from *Nfatc4*^−/−^ and WT mice after neomycin treatment. **(C)** The numbers of Myo7a^+^/TUNEL^+^ cells in the middle and basal turns were significantly decreased in the cochlear epithelium from *Nfatc4*^−/−^ mice compared to WT mice after neomycin treatment. **(D)** qPCR analysis showed that the expression levels of *Tnf*, *Casp3*, and *Casp8* were decreased in Nfatc4-deficient cochlear epithelium after neomycin damage. Scale bar = 30 μm. \*indicates *p* \< 0.05, \*\*indicates *p* \< 0.01, and \*\*\*indicates *p* \< 0.001 vs. the WT+Neo group. *n* = 5.](fimmu-10-01660-g0005){#F5}

Inhibition of Tnf Production Protected Cochlear Hair Cells Against Neomycin-Induced Damage
------------------------------------------------------------------------------------------

To further investigate the role of the Tnf pathway in hair cell damage, we used Len, an inhibitor of Tnf production ([@B19], [@B20]). Len (1 or 10 μM) and 1 mM neomycin were added simultaneously to the medium for 6 h, and cochlear epithelia were harvested after an additional 24 h ([Figure 6A](#F6){ref-type="fig"}). qPCR was performed to confirm the inhibitory effect of Len on Tnf production, and the results showed that Len significantly decreased the mRNA expression of *Tnf* in neomycin-injured cochlear epithelium ([Figure 6E](#F6){ref-type="fig"}). In the neomycin-treated group, there were 3.60 ± 1.14 and 1.00 ± 0.71 IHCs/100 μm and 7.80 ± 1.10 and 4.80 ± 0.83 OHCs/100 μm in the middle and basal turns, respectively ([Figures 6B--D](#F6){ref-type="fig"}). In the neomycin combined with 1 μM Len-treated group, there were 3.20 ± 0.84 and 4.20 ± 0.84 IHCs/100 μm and 14.00 ± 0.71 and 8.20 ± 0.83 OHCs/100 μm in the middle and basal turns, respectively ([Figures 6B--D](#F6){ref-type="fig"}). In the neomycin combined with 10 μM Len-treated group, there were 11.80 ± 0.83 and 7.20 ± 1.30 IHCs/100 μm and 47.20 ± 2.28 and 25.20 ± 1.48 OHCs/100 μm in the middle and basal turns, respectively ([Figures 6B--D](#F6){ref-type="fig"}). The number of hair cells was significantly greater in the neomycin combined with Len-treated cochlear epithelium compared to the neomycin-treated group, indicating that inhibition of Tnf production significantly reduced neomycin-induced hair cell loss.

![Inhibition of Tnf production protected cochlear hair cells against neomycin-induced damage. **(A)** The diagram of the assay for **(B--D)**. Cochlear sensory epithelium samples from P2 WT mice were dissected out and allowed to recover for 12 h. The samples were treated with 1 mM neomycin and Len (1 or 10 μM) for 6 h, allowed to recover for 24 h, and then used for immunostaining. **(B)** Representative Myo7a immunofluorescence staining after drug treatment (neomycin alone or combined with Len). **(C,D)** Len treatment protected against neomycin-induced hair cell loss. **(E)** qPCR analysis showed that Len significantly decreased the mRNA expression of *Tnf* in neomycin-injured cochlear epithelium. Scale bar = 50 μm. \*indicates *p* \< 0.05, \*\*indicates *p* \< 0.01, and \*\*\*indicates *p* \< 0.001. *n* = 5.](fimmu-10-01660-g0006){#F6}

To further confirm the effect of inhibiting Tnf on neomycin-induced ototoxicity, etanercept (ETA, 1 or 10 μg/ml), a soluble Tnf decoy receptor drug that binds to Tnf and inhibits its interaction with endogenous Tnf receptors ([@B21], [@B22]), was used to block the Tnf pathway. Significantly more hair cells were observed in the neomycin combined with ETA (10 μg/ml)-treated cochlear epithelium compared to the neomycin-treated group in the middle and basal turns ([Figure S1](#SM1){ref-type="supplementary-material"}, *p* \< 0.05), indicating that ETA administration significantly reduced neomycin-induced hair cell loss and further confirmed the protective role of Tnf inhibition in cochlear hair cells.

Discussion {#s4}
==========

Some genes related to the immune system have been shown to play diverse roles in cochlear development, hearing function, and hearing protection. For example, macrophage migration inhibitory factor (Mif), an inflammatory cytokine, acts as a neurotrophin in the developing inner ear ([@B23]). *Mif* knockout mice are hearing impaired and demonstrate fewer sensory hair cells and altered innervation of the organ of Corti. A missense mutation of *NLRP3*, which encodes the NLRP3 inflammasome, causes autosomal-dominant sensorineural hearing loss accompanied by autoinflammatory signs and symptoms ([@B24]).

Aging ([@B4], [@B25]), cisplatin treatment ([@B26]--[@B28]), and noise injury ([@B1]) have all been shown to activate the immune system and to lead to the production of inflammatory mediators in the cochlea, and these factors can have diverse actions in the inner ear. For example, activation of Toll-like receptor 4 activates the innate immune system and promotes sensory cell degeneration and cochlear dysfunction after acoustic injury ([@B1]), while activation of the adenosine A1 receptor protects against cisplatin ototoxicity in the cochlea by suppressing the NOX3/STAT1 inflammatory pathway ([@B27]). In addition, controlling inflammation by inhibition of STAT1 via siRNA protects against cisplatin-induced hair cell apoptosis ([@B26]).

In the embryonic brain, NFAT signaling is required to stimulate axon outgrowth ([@B29]), and Nfatc4 inhibits the expression of growth-associated protein 43 during neuronal maturation ([@B30]). In addition, the NMDAR-Nfatc4-BDNF pathway contributes to cell survival during the development of cortical neurons ([@B11]). In this study, we showed that Nfatc4 was expressed in mouse cochlear hair cells, but deficiency of Nfatc4 did not result in hair cell loss or in hearing malfunction ([Figure 1](#F1){ref-type="fig"}), suggesting that Nfatc4 is not involved in the development of the auditory system.

The overproduction of ROS contributes to aminoglycoside-induced and noise exposure-induced hair cell death and associated hearing loss ([@B2], [@B15], [@B31]), and it has been reported that ROS activate Nfatc4 and lead to apoptosis in renal tubular cells ([@B32]). In this study, we showed that neomycin treatment activated Nfatc4 in cochlear hair cells, as demonstrated by the nuclear translocation of the Nfatc4 protein and the increased mRNA expression levels of *Nfatc4* ([Figure 4](#F4){ref-type="fig"}), suggesting that Nfatc4 activation is involved in hair cell apoptosis. Nfatc4-deficient cochlear hair cells showed lower sensitivity to neomycin treatment and noise exposure ([Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}), again indicating that Nfatc4 activation mediates hair cell death in response to injury.

It was previously reported that Nfatc4 works upstream of Tnf-induced apoptosis of glioma cells ([@B12]), and the recruitment of Nfatc4 to the *Tnf* promoter has been shown to be required in ultraviolet radiation-induced cell death in mouse embryonic fibroblasts ([@B18]). The noise exposure-mediated increase in Tnf expression has also been reported previously ([@B3], [@B5]). In this study, we found that neomycin treatment resulted in the activation of the Tnf-induced cell apoptosis pathway, as demonstrated by increased mRNA levels of *Tnf*, *Casp8*, and *Casp3* ([Figure 4](#F4){ref-type="fig"}). In addition, the inhibition of Tnf production with Len or blocking Tnf with ETA significantly protected hair cells against neomycin-induced hair cell loss, suggesting that the Tnf pathway mediated hair cell death in response to neomycin injury ([Figure 6](#F6){ref-type="fig"} and [Figure S1](#SM1){ref-type="supplementary-material"}). Moreover, we found that the mRNA levels of *Tnf*, *Casp8*, and *Casp3* were significantly decreased in Nfatc4-deficient cochlear epithelium compared with controls ([Figure 5](#F5){ref-type="fig"}), indicating that Nfatc4 deficiency inhibited the neomycin-induced activation of the Tnf pathway and subsequent apoptosis. Although a previous study reported that Tnf-α treatment results in NFAT nuclear translocation via activation of calcineurin in the neuroblastoma cells ([@B33]), in our experiments Nfatc4 nuclear translocation was not blocked by Tnf inhibition using Len ([Figure S3](#SM3){ref-type="supplementary-material"}), suggesting that Nfatc4 works upstream of Tnf in neomycin-induced hair cell apoptosis. Taken together, these results suggest that the protective role of Nfatc4 deficiency in cochlear hair cells might be attributed to the inhibition of Tnf-mediated apoptosis.

In other tissues, including the brain, the mechanism(s) of Nfatc4 activation after injury mainly focus on calcineurin/NFAT signaling. The calcineurin/NFAT signaling inhibitors cyclosporin A (CsA) and tacrolimus (FK506) have been used in studies on the role of NFAT signaling in the survival of leukemia cells ([@B34]), T cell activation ([@B35]), and myeloid haematopoiesis ([@B36]). We used these two inhibitors to test whether they could protect cochlear hair cells against ototoxic drugs. We found that CsA administration had no obvious effect on the survival of cochlear hair cells ([Figure S2](#SM2){ref-type="supplementary-material"}). Neomycin-induced hair cell damage was only slightly attenuated by FK506 administration ([Figure S2](#SM2){ref-type="supplementary-material"}), and the protective effect of FK506 was far less than that of Nfatc4 deficiency or Len (a Tnf inhibitor). The possible role of calcineurin in the Nfatc4 activation in cochlear hair cells remains unclear.

In summary, this study reports the expression and function of Nfatc4 in cochlear hair cells. Although Nfatc4 does not appear to be involved in the development of cochlear hair cells or hearing function, Nfatc4 activation appears to mediate hair cell apoptosis induced by aminoglycoside drugs and noise exposure. Moreover, we have shown that Tnf-mediated apoptosis is involved in hair cell death and that Nfatc4 deficiency suppresses the activation of the Tnf pathway, thus protecting hair cells against caspase-mediated apoptosis after neomycin injury. These results suggest that Nfatc4 inhibition might be a new therapeutic target for the prevention of aminoglycoside and noise-induced hearing loss.
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Etanercept treatment protected cochlear hair cells against neomycin-induced damage. **(A)** The diagram of the assay for **(B--D)**. Cochlear sensory epithelium samples from P2 WT mice were dissected out and allowed to recover for 12 h. The samples were treated with 1 mM neomycin and etanercept (ETA, 1 μg/ml or 10 μg/ml) for 6 h, allowed to recover for 24 h, and then used for immunostaining. **(B)** The representative Myo7a immunofluorescence staining after drug treatment (neomycin alone or combined with ETA). **(C,D)** ETA treatment at 10 μg/ml protected against neomycin-induced hair cell loss. Scale bar = 20 μm. ^\*\*\*^indicates *p* \< 0.001. *n* = 5.

###### 

Click here for additional data file.

###### 

The effects of calcineurin/NFAT signaling inhibitors on the survival of cochlear hair cells against neomycin-induced damage. **(A)** The diagram of the assay for **(B,C)**. Cochlear sensory epithelium samples from P2 WT mice were dissected out and allowed to recover for 12 h. The samples were treated with 1 mM neomycin and CsA/FK506 for 6 h, allowed to recover for 24 h, and then used for immunostaining. **(B)** The representative Myo7a immunofluorescence staining after drug treatment. **(C)** Quantification of the number of HCs. Scale bar = 20 μm. ^\*^indicates *p* \< 0.05. *n* = 5.

###### 

Click here for additional data file.

###### 

Immunofluorescence staining of Nfatc4 in neomycin combined with Len treated cochlear epithelium. Scale bar = 10 μm.

###### 

Click here for additional data file.

Tnf

:   tumor necrosis factor

Nfatc4

:   Nuclear factor of activated T cells 4

NMDAR

:   N-methyl-D-aspartate receptor

BDNF

:   brain derived necrosis factor

ROS

:   reactive oxygen species

WT

:   wild type

ABR

:   auditory brainstem response

TDT system

:   Tucker Davies Technologies

PFA

:   4% paraformaldehyde

Myo7a

:   myosin VIIA

IHCs

:   inner hair cells

OHCs

:   outer hair cells

Casp8

:   caspase 8

Casp9

:   caspase 9

Casp3

:   caspase 3

Len

:   Lenalidomide

ETA

:   Etanercept

Mif

:   migration inhibitory factor

TLR 4

:   Toll-like receptor 4

NOX3

:   NADPH oxidase 3

STAT1

:   signal transducers and activators of transcription 1

CsA

:   Cyclosporin A

FK506

:   Tacrolimus.
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